srch

Use our partner XING to contact directly the staff of Blueprint Medicines (Switzerland) GmbH, Zug.

Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. We create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise ...

MD Bioproducts is a manufacturer and provider of antibodies, reagents and custom assays for inflammatory and autoimmune diseases, neurology, metabolism, ...

Blueprint Medicines (Switzerland) GmbH in Zug ✓ aktiv ✓ Gegründet 2018 ✓ Management: Georg Meyer u.a ✓ Letzte Änderung: 10.12.2021.

GAVRETO is jointly commercialized in the U.S. by Blueprint Medicines and Genentech, a wholly owned member of the Roche Group, under Blueprint Medicines’ collaboration with Roche.

Das Unternehmen Blueprint Medicines (Switzerland) GmbH ist eine GmbH mit Sitz in Zug, im Kanton Zug, die im Jahr 2018 gegründet wurde.

Zug, Switzerland Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease.

Company Description: Blueprint Medicines (Switzerland) GmbH is located in Zug, ZUG, Switzerland and is part of the Scientific Research and Development ...

15.12.2020 · Blueprint Medicines is headquartered in the U.S. and as a result, personal information about you will be processed by Blueprint Medicines in the U.S. Blueprint Medicines may contract with service providers to process personal information on Blueprint Medicine’s behalf; these service providers may be located outside of the EEA, Switzerland and UK.

Blueprint Medicines Appoints Daniella Beckman to its Board of Directors Dec 07, 2021 Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) More News Events and presentations Nov 29, 2021 Blueprint Medicines Conference Call Oct 28, 2021 Q3 2021 Blueprint Medicines Corp Conference Call More events and presentations

Blueprint Medicines Global Headquarters. 45 Sidney Street. Cambridge, MA 02139. (617) 374-7580. info@blueprintmedicines.com. EU Office. Blueprint Medicines (Switzerland) GmbH. Baarerstrasse 8. 6300 Zug.

MD Bioproducts GmbH. MD Bioproducts is a manufacturer and provider of antibodies, reagents and custom assays for inflammatory and autoimmune diseases, neurology, metabolism, immunology, endocrinology, and oncology research. With 30 years of experience, MD Bioproducts offers pharmaceutical, biotech, academic and government communities tools to ...

Blueprint Medicines will not transfer personal information from or concerning individuals in the EEA, Switzerland, or the United Kingdom to third parties unless such third parties have entered into a written agreement with Blueprint Medicines requiring that the third party provide at least the same level of privacy protection as is

Blueprint Medicines (Switzerland) GmbH is a Limited Liability Company based in Zug, in the canton of Zug, founded in 2018. Its identification number UID is CHE-499.149.707. It is active in "other research and experimental development on natural sciences and engineering".

Cambridge, MA 02139 (617) 374-7580 info@blueprintmedicines.com. EU Office Blueprint Medicines (Switzerland) GmbH. Baarerstrasse 8 6300 Zug Switzerland ...

Blueprint Medicines (Switzerland) GmbH Baarerstrasse 8 6300 Zug Switzerland. Patients, families and healthcare professionals For medical inquiries or questions about opportunities to participate in clinical trials: United States [email protected] 1 …

Free and open company data on Switzerland company Blueprint Medicines (Switzerland) GmbH (company number 1360094), Baarerstrasse, 8, Zug, ...

Blueprint Medicines is a precision therapy company striving to improve human health. With a focus on genomically defined cancers, rare diseases and cancer ...